Traverse Biosciences' Seed VC Round

Traverse Biosciences raised a round of funding on June 06, 2014. Investors include Long Island Emerging Technologies Fund.

Traverse Biosciences is commercializing an edible prescription medication for the prevention and control of canine periodontal disease, which affects approximately 80% of dogs over the age of two.…

Articles about Traverse Biosciences' Seed VC Round: